## **What is peripheral vascular disease (PVD)?**
Peripheral vascular disease (PVD) is a circulatory condition in which narrowed or blocked blood vessels reduce blood flow to the limbs, most commonly the legs. During an initial acute PVD encounter, patients may present with sudden limb pain, coldness, numbness, or color changes, all of which require urgent attention. The initial evaluation of PVD typically involves reviewing the patient’s history, identifying risk factors such as diabetes, smoking, or hypertension, and conducting physical assessments to confirm the presence of vascular obstruction. Clinicians ensure appropriate diagnoses are made by using imaging studies and clinical findings, which are evaluated during the initial workup.
Following stabilization, rehabilitation therapy may be recommended to improve mobility and circulation. The use of high-risk medications, such as anticoagulants or antiplatelets, must be carefully managed, as these are vital in treatment but can increase bleeding risk.
PVD is often linked to other serious health concerns. Patients with chronic kidney disease, acute kidney injury, or end-stage renal disease share similar risk factors like diabetes and hypertension, which can worsen vascular problems. Management may involve prescribing ACE inhibitors or having ARB therapy prescribed to control blood pressure and protect vascular health. In some cases, patients with advanced heart conditions may require a left ventricular assist device, highlighting the overlap between cardiac and vascular disease.
PVD can also contribute to mobility issues and future fall risk, especially in cases of limb ischemia or amputation. For some patients, the condition first presents during urgent care visits or only urgent care visits, reflecting its acute and sometimes unpredictable onset. While not directly vascular, conditions like an acute fracture or lumbar spine region fracture can complicate recovery and mobility in PVD patients. Additionally, careful monitoring of every medication prescribed is essential to avoid drug-drug interactions and ensure that high-risk medications are safely managed.
### **Procedure description**
HCPCS code M1337 is used to report services related to the initial or subsequent evaluation and management of patients with acute peripheral vascular disease (PVD). This condition involves sudden or worsening circulatory problems often requiring urgent assessment or kidney health evaluation to prevent complications such as limb ischemia, tissue damage, and severely compromised immune systems. The evaluation includes clinical examination, diagnostic testing, and development of treatment plans to address the vascular status and related health concerns of patients with a diagnosis.
Providers use this code to document specific encounters focused on acute PVD diagnosis, monitoring, and care coordination. Such services often occur in hospital settings, outpatient clinics, or specialized vascular centers and may include assessment of risk factors such as high-risk medications, coexisting chronic kidney disease, and other comorbidities. The goal is to stabilize vascular function, manage symptoms, and reduce risks of adverse outcomes.
### **HCPCS code M1337 documentation requirements**
To support billing for HCPCS Code M1337, providers must maintain thorough documentation that reflects the complexity and acuity of the PVD encounter:
- A clear record of the initial evaluation or follow-up visit for acute PVD, demonstrating clinical findings and patient status.
- Documentation of appropriate diagnoses, including acute PVD and related conditions such as acute kidney injury or coexisting chronic diseases.
- Notes on patient history that impact vascular care and treatment, including past treatments, medications (such as ACE inhibitors), and hospitalizations.
- Descriptions of diagnostic procedures performed, clinical decision-making, and treatment plans.
- Evidence of coordination with other healthcare providers or rehabilitation therapy as needed.
- Monitoring and follow-up plans to track patient progress and adjustments in care.
## **M1337 billing requirements**
Providers billing HCPCS Code M1337 must ensure:
- The service is clearly linked to acute peripheral vascular disease management.
- Documentation supports the medical necessity of the encounter and the complexity of care.
- Each patient encounter is distinctly recorded, with relevant dates and outcomes.
- Compliance with payer-specific guidelines regarding acute condition treatment and billing.
- Accurate linkage of interventions related to the evaluation, management, and follow-up, including any monitoring and post-administration care.
## **Other relevant codes**
- **CPT 93922**: Noninvasive physiologic studies of upper or lower extremity arteries, unilateral or bilateral.
- **CPT 93923**: Noninvasive physiologic studies of extremity veins.
- **ICD-10 code I70.2**: For atherosclerosis of native arteries of the extremities (used for diagnosis).
- **CPT 99281–99285** – Emergency department evaluation and management codes for acute conditions.
Frequently asked questions